Merck & Co., Inc (MRK)
Exchange: New York Stock Exchange
Currency: USD
Price: 0.00 ()
Summary
| 52 Week range | 200d Moving Avg. | Beta |
| 0.00 – 0.00 | 0.00 | 0.00 |
| Dividend | Dividend Yield | Ex-Dividend date |
| 0.00 | 0.00% | 0000-00-00 |
| P/E Ratio | Latest EPS | DGR 3 years |
| 15.40 | 2.32 | 9.88% |
Overvalued
Low
N.A.
High
Slow
Dividend Growth
Fast
Profile
Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company’s relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.
| Sector: | Industry: | |
| Health Technology | Pharmaceuticals: Major | |
Total ESG Score
28 – 47 percentile
Environment
3 – 4 percentile
Social
16 – 4 percentile
Governance
13 – 4 percentile
Controversy level
3
MSCI ESG-Rating
AAA
see MSCI ESG rating explained
Dividend Safety Metrics
| Latest EPS | 2.32 | |
| Annual Payout | 0.00 | |
| Payout Ratio | 0.00% | |
| Dividend growth | Years | |
| Dividend Score | 73 | |
| Dividend Coverage Ratio | 0.00 | |
| Altman-Z score | 0.00 |
Merck & Co., Inc (MRK) Valuation
Merck & Co., Inc current dividend yield of 0.00% is -100% below its 5-year average. The 5-year average dividend yield is 2.98% (see red-line in chart). This indicates the stock looks overvalued today.
Merck & Co., Inc (MRK) Performance
The chart below displays the total price return(%) of Merck & Co., Inc for different periods:
Merck & Co., Inc (MRK) Total Return
The chart below displays the (CAGR) total return (%) including all dividends paid of Merck & Co., Inc for different periods:
Dividend Scorecard
| Dividend Yield (TTM) | Annual Payout | Payout Ratio | Dividend growth |
| 0.00 | 0.00 | 0.00% | Years |
Dividend Growth Summary
| 3 Year Growth Rate (CAGR) | 9.88% |
| 5 Year Growth Rate (CAGR) | 7.37% |
| 10 Year Growth Rate (CAGR) | 5.40% |
Dividend Growth Rates History
| Year | Payout Amount | Annual Payout Growth (YoY) |
|---|---|---|
| 2022 | 0.690 | -73.9% |
| 2021 | 2.640 | 6.5% |
| 2020 | 2.480 | 9.7% |
| 2019 | 2.260 | 13.6% |
| 2018 | 1.990 | 5.3% |
| 2017 | 1.890 | 2.2% |
| 2016 | 1.850 | 2.2% |
| 2015 | 1.810 | 2.3% |
| 2014 | 1.770 | 2.3% |
| 2013 | 1.730 | 2.4% |
| 2012 | 1.690 | 8.3% |
| 2011 | 1.560 | 2.6% |
| 2010 | 1.520 | 0.0% |
| 2009 | 1.520 | 0.0% |
| 2008 | 1.520 | 0.0% |
Merck & Co., Inc (MRK) Dividend Payment History